Clinical Trial Update: Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated isotretinoin for its effect on immune activation in HIV-1–infected individuals with incomplete CD4+ T cell recovery; the study is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-09-05